You are here

  • Home
  • Archive
  • Volume 22, Issue 4
  • The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

Article metrics

Article menu

Download PDFPDF

XML
Methods
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

 

Online download statistics by month:

Online download statistics by month: July 2017 to March 2024

AbstractFullPdf
Jul 201705611
Aug 201701166205
Sep 201701041145
Oct 2017050177
Nov 2017040462
Dec 2017016240
Jan 2018041744
Feb 2018035341
Mar 2018017233
Apr 2018025028
May 2018030133
Jun 2018014815
Jul 2018014718
Aug 2018017926
Sep 2018044947
Oct 2018032031
Nov 2018030723
Dec 2018031514
Jan 2019026030
Feb 2019028630
Mar 2019021435
Apr 201909212
May 2019014426
Jun 2019011829
Jul 201909124
Aug 201907213
Sep 201907116
Oct 2019013214
Nov 201908818
Dec 201908112
Jan 202008511
Feb 202008120
Mar 202006412
Apr 20200749
May 202006513
Jun 202005113
Jul 20200548
Aug 202006220
Sep 20200597
Oct 202009522
Nov 202008524
Dec 202009324
Jan 202107420
Feb 202106020
Mar 202107520
Apr 202108915
May 202107123
Jun 202106016
Jul 202104614
Aug 202106420
Sep 202104829
Oct 202108261
Nov 202108248
Dec 202105526
Jan 202205825
Feb 202206827
Mar 202206415
Apr 202205318
May 202205837
Jun 202207326
Jul 202205016
Aug 20220609
Sep 202208619
Oct 202206924
Nov 202204219
Dec 202203412
Jan 202306218
Feb 20230718
Mar 202304421
Apr 202304330
May 202303026
Jun 202303028
Jul 202302423
Aug 202303625
Sep 202305227
Oct 202303128
Nov 2023023331
Dec 202306111
Jan 202403316
Feb 202403511
Mar 202407222
Total0115322819